(Press-News.org) Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.
The study was led by the Science and Technology Facilities Council (STFC) Central Laser Facility (CLF) and used advanced laser imaging techniques to identify structural details of a mutated protein which help it to evade drugs that target it.
It is published (19/03/2024) in the journal, Nature Communications and lays the groundwork for future research into more effective, long-lasting cancer therapies.
The Epidermal Growth Factor Receptor (EGFR) is a protein that sits on the surface of cells and receives molecular signals that tell the cell to grow and divide. In certain types of cancer, mutated EGFR stimulate uncontrolled growth, resulting in tumours.
Various cancer treatments block and inhibit mutant EGFR to prevent tumour formation, but these are limited as eventually cancerous cells commonly develop further EGFR mutations that are resistant to treatment.
Until now, how exactly these drug-resistant EGFR mutations drive tumour growth was not understood, hindering our ability to develop treatments that target them.
In this latest study, scientists at CLF have obtained super-resolution images of a drug-resistant EGFR mutation known to contribute to lung cancer. This was achieved using an advanced laser imaging technique developed by STFC for this purpose called Fluorophore Localisation Imaging with Photobleaching, or FLImP.
FLImP analysis revealed structural details as small as two nanometres and showed for the first time with this level of precision how molecules in the drug-resistant EGFR mutation interact.
Additional analysis by the Biomolecular & Pharmaceutical Modelling Group at University of Geneva (UNIGE) used advanced computer simulations that combined with the FLImP analysis were able to provide atomistic details of the mutant EGFR complexes.
From this, the team were able to compare the structural details of the mutated and healthy EGFR to identify interfaces between interacting molecules in the drug-resistant mutation critical for tumour growth.
Professor Marisa Martin-Fernandez, Leader of the Octopus Group at CLF, which led the study, said: “This finding is the culmination of years of research and technological development at CLF and our partner institutions and we’re extremely excited about its potential to inform the course of cancer research going forward. If this interface proves to be an effective therapeutic target, it could provide an entirely new approach to much needed pharmaceutical development.”
The team then introduced additional mutations to the drug-resistant EGFR in in cultured lung cells and in mice that interfered with the newly discovered interfaces.
In these experiments, one of the additional EGFR mutations was shown to block cancer growth, with mice developing no tumours, further indicating that the ability of this EGFR mutation to promote cancer indeed depends on these interfaces.
Dr Gilbert Fruhwirth, Leader of the Imaging Therapies and Cancer group at King's College London who validated results in live animals, said: "This research has become possible through the combination of a variety of different imaging technologies, ranging from single molecules to whole animals, and demonstrates the power of imaging to better understand the inner workings of cancer. We are extremely pleased about this successful collaboration and look forward to develop this pharmaceutical opportunity further as part of this team.”
Researchers hope that these interfaces could act as potential targets for new cancer therapies that overcome resistance acquired by EGFR mutations.
Professor Francesco Luigi Gervasio, Leader of the Biomolecular & Pharmaceutical Modelling Group at UNIGE, said: “This breakthrough was made possible by a combination of state-of-the-art simulations and experimental techniques that can now ‘visualise’ the structure and dynamics of important cancer targets such as EGFR in unprecedented detail.”
Dr. Yiannis Galdadas at UNIGE, who performed the simulations, said: "The simulations were able to push the effective resolution of the microscope beyond the limits of imagination. It's almost possible to ‘touch’ the mutation site and see its effect."
Further studies at CLF are currently testing the research method on other EGFR mutations known to contribute to lung cancer. They also hope to establish whether this interface plays a role in the development of other cancers including brain cancer.
Notes to editors
The full paper can be read in Nature Communications (DOI 10.1038/s41467-024-46284-x): https://www.nature.com/articles/s41467-024-46284-x
For any enquiries and interview requests, or for an embargoed copy of the paper, please contact:
Alex Fyans
Research Media Manager
Science and Technologies Facilities Council
Email: Alexander.Fyans@stfc.ac.uk
Mobile: 07518 299 657
About the Central Laser Facility
The Central Laser Facility (CLF) at the STFC Rutherford Appleton Laboratory is one of the world’s leading laser facilities, providing scientists from the UK and Europe with an unparalleled range of state-of-the-art laser technology. CLF’s wide-ranging applications include experiments in physics, chemistry, and biology, accelerating subatomic particles to high energies, probing chemical reactions on the shortest timescales, and studying biochemical and biophysical process critical to life itself.
About the Science and Technology Facility Council
The Science and Technology Facilities Council (STFC), part of UK Research and Innovation (UKRI), is the UK’s largest public funder of research into particle and nuclear physics, astronomy and astrophysics, and space science. We operate five national laboratories across the UK which, supported by a network of additional research facilities, increase our understanding of the world around us and develop innovative technologies in response to pressing scientific and societal issues. We also facilitate UK involvement in a number of international research activities including CERN, the James Webb Space Telescope, and the Square Kilometre Array Observatory.
END
Scientists identify Achilles heel of lung cancer protein
Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.
2024-03-19
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Insulin affects the recycling of cellular power plants
2024-03-19
The hormone insulin controls many cellular processes and adapts them to the body’s current energy supply. One of the insulin-regulated processes is the quality control of cellular power plants in neurons, Angelika Harbauer and her team at the Max Planck Institute for Biological Intelligence discovered. When sufficient energy is available in the body, insulin facilitates the elimination of defective mitochondria. When energy is scarce or when the insulin signal is interrupted, mitochondrial recycling is reduced and cells continue to use their old power plants, even potentially damaged ones. The continued operation of faulty mitochondria could affect ageing ...
Brown researchers develop brain-inspired wireless system to gather data from salt-sized sensors
2024-03-19
PROVIDENCE, R.I. [Brown University] — Tiny chips may equal a big breakthrough for a team of scientists led by Brown University engineers.
Writing in Nature Electronics, the research team describes a novel approach for a wireless communication network that can efficiently transmit, receive and decode data from thousands of microelectronic chips that are each no larger than a grain of salt.
The sensor network is designed so the chips can be implanted into the body or integrated into wearable devices. Each submillimeter-sized silicon sensor mimics ...
New research highlights strong demand for data on personalized risk of preeclampsia
2024-03-19
South San Francisco, Calif. (March 19, 2024) - A new study in BMC Pregnancy and Childbirth finds that objective information about risk of preeclampsia could be key to driving patient behavior change and creates motivation among pregnant patients to follow provider recommendations on prevention, even among those who are medication-hesitant.
Key findings include:
91% of the study participants desired predictive testing for preeclampsia
94% reported they would want blood pressure monitoring at home if found to be at high risk
88% reported they would be more motivated to follow their provider’s medication recommendations if at high risk. This finding was consistent ...
Toxic metal particles can be present in cannabis vapes even before the first use
2024-03-19
NEW ORLEANS, March 19, 2024 — Vapes have often been heralded as a “safer” way to consume either nicotine or cannabis, where legal to do so. But the devices present their own suite of risks that are slowly being revealed as they undergo increasing research and regulation. Now, researchers have discovered that nano-sized toxic metal particles may be present in cannabis vaping liquids even before the vaping device is heated, and the effect is worse in unregulated products.
The researchers will present their results today at the spring meeting of the American Chemical Society (ACS). ACS Spring 2024 is a hybrid meeting being held virtually and in person March ...
Is food waste the key to sustainable, plastic-free diapers and sanitary pads?
2024-03-19
NEW ORLEANS, March 19, 2024 — Once thrown away, disposable items such as diapers and sanitary pads can take hundreds of years to decompose, because their absorbent parts and waterproof layers contain plastics and other synthetic polymers. But now, researchers are replacing these materials with porous components made from protein biomass that is often discarded by the food and agricultural industries. These components are sustainable and biodegradable, and could potentially allow future diapers and sanitary pads to be flushed down a toilet or used as ...
Molecular crystal motors move like microbes when exposed to light
2024-03-19
NEW ORLEANS, March 19, 2024 — At first glance, Rabih O. Al-Kaysi’s molecular motors look like the microscopic worms you’d see in a drop of pond water. But these wriggling ribbons are not alive; they’re devices made from crystallized molecules that perform coordinated movements when exposed to light. With continued development, Al-Kaysi and colleagues say, their tiny machines could be used by physicians as drug-delivery robots or engineered into arrays that direct the flow of water around submarines.
The ...
Conversations in an MR scanner provides a novel view of the brain’s language network
2024-03-19
Researchers have revealed new insights into how the brain processes speech and listening during conversations through advanced investigations using functional magnetic resonance imaging (fMRI). In a groundbreaking study published in the esteemed journal Cerebral Cortex, researchers compared brain activity in individuals while both speaking and listening during natural conversational situations.
Conversational interactions are central to the everyday human experience. During conversation, we use language, together with social, and other cognitive skills to flexibly switch between the roles of speaker and listener. In research on ...
When words make you sick
2024-03-19
In a new book, experts in a variety of fields explore nocebo effects – how negative expectations concerning health can make a person sick. It is the first time a book has been written on this subject.
“I think it’s the idea that words really matter. It’s fascinating that how we communicate can affect the outcome. Communication in health care is perhaps more important than the patient recognises,” says Charlotte Blease, who is a researcher at the Department of Women’s and Children’s Health ...
Removal of incorrect penicillin allergy labels by non-specialist healthcare professional feasible
2024-03-19
Patients who may have been mis-labelled as allergic to penicillin could be safely offered a dose of the oral antibiotic to demonstrate that they could take it without harm, following a new trial.
In a new study published in the Journal of Infection funded by the National Institute for Health and Care Research (NIHR), academics and clinicians ran a study in three UK hospitals to assess the feasibility of non-allergy specialist healthcare professionals delivering direct oral penicillin ‘challenges’, without doing allergy tests, where low risk patients ...
Is your partner’s disturbed sleep keeping you up at night? Letting go of unattainable dreams may keep you both happy in bed
2024-03-19
We all know that getting a good night’s sleep is vital for physical and mental health. Yet many people share a bed with a partner who can’t help disturb their sleep. For example through their insomnia, frequently going to the bathroom, snoring, or a tendency to toss and turn in bed. Unsurprisingly, research has shown that poor sleep can lead to increased anger and decreased satisfaction with the relationship. But can we avoid falling in this trap, short of sleeping in separate bedrooms?
Yes, if we are naturally good – or learn to be so – at goal disengagement, the mental ...
LAST 30 PRESS RELEASES:
First new treatment for asthma attacks in 50 years
Certain HRT tablets linked to increased heart disease and blood clot risk
Talking therapy and rehabilitation probably improve long covid symptoms, but effects modest
Ban medical research with links to the fossil fuel industry, say experts
Different menopausal hormone treatments pose different risks
Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL
Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention
Discovering the traits of extinct birds
Are health care disparities tied to worse outcomes for kids with MS?
For those with CTE, family history of mental illness tied to aggression in middle age
The sound of traffic increases stress and anxiety
Global food yields have grown steadily during last six decades
Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study
North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabl
Higher levels of democracy and lower levels of corruption are associated with more doctors, independent of healthcare spending, per cross-sectional study of 134 countries
In major materials breakthrough, UVA team solves a nearly 200-year-old challenge in polymers
Wyoming research shows early North Americans made needles from fur-bearers
Preclinical tests show mRNA-based treatments effective for blinding condition
Velcro DNA helps build nanorobotic Meccano
Oceans emit sulfur and cool the climate more than previously thought
Nanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry
Rare, mysterious brain malformations in children linked to protein misfolding, study finds
Newly designed nanomaterial shows promise as antimicrobial agent
Scientists glue two proteins together, driving cancer cells to self-destruct
Intervention improves the healthcare response to domestic violence in low- and middle-income countries
State-wide center for quantum science: Karlsruhe Institute of Technology joins IQST as a new partner
Cellular traffic congestion in chronic diseases suggests new therapeutic targets
Cervical cancer mortality among US women younger than age 25
Fossil dung reveals clues to dinosaur success story
New research points way to more reliable brain studies
[Press-News.org] Scientists identify Achilles heel of lung cancer proteinResearchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.